Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017)
Aquestive Therapeutics (AQST) posted Preferred Dividend Payments of $626000.0 for Q4 2017, little changed on a QoQ basis from $626000.0 in Q3 2017.
Analysis
Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017) Analysis & Trends
Aquestive Therapeutics has reported Preferred Dividend Payments for 1 years, with the latest figure at $626000.0 in Q4 2017.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $626000.0 in Q4 2017; TTM through Dec 2018 was $626000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $2.5 million, changed N/A from the prior year.
- Preferred Dividend Payments was $626000.0 for Q4 2017 at Aquestive Therapeutics, roughly flat from $626000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $626000.0 in Q3 2017, with the low at $615000.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | - |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Aquestive Therapeutics | 638.72 Mn | 540.23 Mn | 9.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 626,000.00 |
| Sep 30, 2017 | 626,000.00 |
| Jun 30, 2017 | 615,000.00 |